Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Coombs research

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jul 26, 2021 2:49pm

162 Views

Post# 33605231

RE:RE:The Coombs research

I might add that the agreement with the Canadian government's National Microbio Lab has a great deal of potential and could result in something very substantial, especially with the new variants that are starting to show up because in all of Dr Coombs work and in the early work of Dr Kobasa 1433 showed remarklable virus killing abilities.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec